Gelesis (GLS) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free GLS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Gelesis Short Interest DataCurrent Short Volume515,000 sharesPrevious Short Volume513,100 sharesChange Vs. Previous Month+0.37%Dollar Volume Sold Short$101,712.50Short Interest Ratio / Days to Cover1.5Last Record DateMarch 15, 2023Outstanding Shares73,333,000 sharesFloat Size19,040,000 sharesShort Percent of Float2.70%Today's Trading Volume185,100 sharesAverage Trading Volume386,034 sharesToday's Volume Vs. Average48% Short Selling Gelesis ? Sign up to receive the latest short interest report for Gelesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGLS Short Interest Over TimeGLS Days to Cover Over TimeGLS Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Gelesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2023515,000 shares $101,712.50 +0.4%2.7%1.5 $0.20 2/28/2023513,100 shares $138,537.00 +0.5%2.7%2.5 $0.27 2/15/2023510,800 shares $142,972.92 -28.2%2.7%2.5 $0.28 1/31/2023711,800 shares $218,878.50 +7.2%3.5%3.7 $0.31 1/15/2023664,200 shares $235,791.00 +4.2%3.3%4.3 $0.36 12/30/2022637,300 shares $185,071.92 +16.0%3.1%4.3 $0.29 12/15/2022549,200 shares $122,581.44 -11.3%2.7%4.1 $0.22 11/30/2022618,900 shares $228,993.00 -13.6%3.1%4 $0.37 11/15/2022716,300 shares $364,596.70 +6.7%3.5%5 $0.51 10/31/2022671,100 shares $250,118.97 -22.6%3.3%4.8 $0.37 10/15/2022867,300 shares $782,738.25 -12.7%3.9%7.4 $0.90 9/30/2022993,800 shares $1.07 million +78.2%4.6%8.9 $1.08 9/15/2022557,600 shares $641,240.00 -9.6%2.6%4.4 $1.15 8/31/2022616,600 shares $746,086.00 -7.5%2.8%6 $1.21 8/15/2022666,700 shares $926,713.00 -8.2%3.1%5.8 $1.39 7/31/2022726,500 shares $1.05 million -12.4%3.4%6.9 $1.44 7/15/2022829,400 shares $1.19 million No Change3.8%7.4 $1.43 GLS Short Interest - Frequently Asked Questions What is Gelesis' current short interest? Short interest is the volume of Gelesis shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 515,000 shares of GLS short. 2.70% of Gelesis' shares are currently sold short. Learn More on Gelesis' current short interest. What is a good short interest ratio for Gelesis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLS shares currently have a short interest ratio of 2.0. Learn More on Gelesis's short interest ratio. What is a good short interest percentage for Gelesis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.70% of Gelesis' floating shares are currently sold short. Is Gelesis' short interest increasing or decreasing? Gelesis saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 515,000 shares, an increase of 0.4% from the previous total of 513,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Gelesis' float size? Gelesis currently has issued a total of 73,333,000 shares. Some of Gelesis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gelesis currently has a public float of 19,040,000 shares. How does Gelesis' short interest compare to its competitors? 2.70% of Gelesis' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Gelesis: Eterna Therapeutics Inc. (1.42%), MIRA Pharmaceuticals, Inc. (0.71%), ABVC BioPharma, Inc. (15.21%), RedHill Biopharma Ltd. (3.07%), Benitec Biopharma Inc. (0.47%), Tonix Pharmaceuticals Holding Corp. (1.48%), Monopar Therapeutics Inc. (2.29%), Imunon, Inc. (4.75%), Purple Biotech Ltd. (0.88%), Elevai Labs, Inc. (0.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Gelesis stock? Short selling GLS is an investing strategy that aims to generate trading profit from Gelesis as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gelesis? A short squeeze for Gelesis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLS, which in turn drives the price of the stock up even further. How often is Gelesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLS, twice per month. The most recent reporting period available is March, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Eterna Therapeutics Short Interest MIRA Pharmaceuticals Short Interest ABVC BioPharma Short Interest RedHill Biopharma Short Interest Benitec Biopharma Short Interest Tonix Pharmaceuticals Short Interest Monopar Therapeutics Short Interest Imunon Short Interest Purple Biotech Short Interest Elevai Labs Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:GLS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals